The Kennesaw, Ga.-based company (NYSE: CRY) is an implantable biological medical device and cardiovascular tissue processing company.
In the early aughts, CryoLife paid millions of dollars to settle suits involving allegedly contaminated tissue products. In July 2005, CryoLife reached a $23.3 million settlement for a class-action lawsuit that alleged it had inadequate disclosures prior to the FDA's August 2002 tissue recall.
Click here to continue reading.
Post a Comment